Medical News

Warning: ./cache is not writeable. Make sure you've set the correct relative or absolute path, and that the location is server-writable. in /var/www/wp-includes/class-simplepie.php on line 1404
  • Add-On Colchicine Cost-Effective After MI
    on 29/03/2020 at 7:30 pm

    ]]>(MedPage Today) -- Low-dose colchicine lowered the risk of ischemic cardiovascular (CV) events after MI, and did so cost-effectively, according to results from the Canadian COLCOT trial. The primary efficacy outcome -- CV death (CVD), MI, stroke...

  • DOAC Works in Cancer-Related VTE, No Tradeoff in Bleeds
    on 29/03/2020 at 7:30 pm

    ]]>(MedPage Today) -- The direct oral anticoagulant (DOAC) apixaban (Eliquis) was as good as the low molecular weight heparin dalteparin (Fragmin) for the treatment of patients with cancer-associated thrombosis -- with no increase in risk of major...

  • Xarelto Slashes VTE After Nonmajor Orthopedic Surgery
    on 29/03/2020 at 4:30 pm

    ]]>(MedPage Today) -- Rivaroxaban (Xarelto) beat low molecular weight heparin for venous thromboembolic prophylaxis after nonmajor lower limb orthopedic surgery, the PRONOMOS trial showed. The direct oral anticoagulant slashed major venous thromboembolic...

  • Surviving a Recession; The Cyber Crime Fighters
    on 29/03/2020 at 4:00 pm

    ]]>(MedPage Today) -- Welcome to this week's edition of Healthcare Career Insights. This weekly roundup highlights healthcare career-related articles culled from across the web to help you learn what's next.Financially, practices and hospitals are...

  • More Cards Report Struggling With Burnout, Survey Finds
    on 29/03/2020 at 3:00 pm

    ]]>(MedPage Today) -- More than one-third of cardiologists reported feeling burnt out, with women and mid-career specialists most likely to report symptoms of burnout, according to a survey of job satisfaction. Of 2,025 cardiologists who responded...

  • More 'Convincing' Data on BP Drop After Renal Denervation
    on 29/03/2020 at 2:30 pm

    ]]>(MedPage Today) -- Blood pressure (BP) reductions achieved with renal denervation remained clinically meaningful in people not taking BP-lowering medications, researchers found. Hypertensive patients had more favorable changes in BP from baseline...

  • Clinical Challenges: Test Your Knowledge on Managing Patients With HIV
    on 29/03/2020 at 2:00 pm

    ]]>(MedPage Today) -- Quiz related to three-part MedPage Today series

  • Clinical Challenges: HIV and the Opioid Epidemic
    on 29/03/2020 at 2:00 pm

    ]]>(MedPage Today) -- One of the consequences of the ongoing opioid epidemic has been that certain subgroups of the U.S. population -- particularly rural communities -- are at an increased risk of HIV transmission. In a viewpoint published in...

  • CKD Patients Aren't Having Mental Health Needs Fully Met
    on 29/03/2020 at 1:30 pm

    ]]>(MedPage Today) -- Chronic kidney disease (CKD) may pose a greater mental health burden than some other chronic conditions, researchers reported. A study that drew on 2015-2018 data from the National Survey of Drug Use and Health compared mental...

  • Inclisiran Tx Dramatically Cuts LDL in Pooled Analysis
    on 29/03/2020 at 1:00 pm

    ]]>(MedPage Today) -- Treatment with inclisiran, an investigational agent targeting PCSK9 via small interfering RNA, reduced LDL cholesterol by more than half in patients with atherosclerotic cardiovascular disease (ASCVD), according to pooled analysis...

  • TAVR: Promising in Low-Risk Patients With Bicuspid Anatomy
    on 29/03/2020 at 12:00 pm

    ]]>(MedPage Today) -- Transcatheter aortic valve replacement (TAVR) conferred good early results even in low-risk patients with bicuspid morphology, according to the Evolut Low Risk Bicuspid Study. By 30 days, all-cause mortality or disabling stroke...

  • AFib Patients Better Off With No Antiplatelet After TAVR
    on 29/03/2020 at 11:34 am

    ]]>(MedPage Today) -- Skipping the antiplatelet agent after transcatheter aortic valve replacement (TAVR, or TAVI) is safer for patients already on oral anticoagulation for other reasons, the POPular TAVI trial showed. Bleeding of any kind occurred...

  • Why Minority Nurses Should Consider Human Resource Roles
    on 29/03/2020 at 10:00 am

    ]]>(MedPage Today) -- Despite roots stretching far back into history, nursing has only been a recognized profession for a little more than a century. While the nursing industry has made great strides since that time, it primarily remains the realm...

  • Will Multiple COVID-19 Strains Hinder Short-Term Vax?
    on 28/03/2020 at 5:00 pm

    ]]>(MedPage Today) -- You passed medical training, now see if you can pass our weekly quiz

  • Phosphate Binder Type Matters in Dialysis
    on 28/03/2020 at 3:00 pm

    ]]>(MedPage Today) -- The type of phosphate binder utilized in dialysis patients may affect rate of hospitalizations, researchers reported. In an analysis of Medicare beneficiaries on dialysis, patients prescribed sucroferric oxyhydroxide (Velphoro...

  • Genotype-Guided P2Y12 Inhibition Narrowly Misses Mark
    on 28/03/2020 at 2:30 pm

    ]]>(MedPage Today) -- Ischemic outcomes after percutaneous coronary intervention (PCI) were not significantly better when patients had P2Y12 inhibitor therapy tailored to their individual genotypes, the TAILOR PCI trial found. People identified as...

  • COVID-19 Perceptions; Diet Among Youth: It's TTHealthWatch!
    on 28/03/2020 at 2:00 pm

    ]]>(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center in El Paso...

  • Diabetes Mediates Renal Outcomes in Some Glomerular Diseases
    on 28/03/2020 at 12:00 pm

    ]]>(MedPage Today) -- Diabetes led to worse renal outcomes in people with certain glomerular diseases, as assessed with biomarkers in a small study. In patients with either focal segmental glomerulosclerosis (FSGS) or membranous nephropathy (MN)...

  • Favorable Results for DOAC After Peripheral Intervention
    on 28/03/2020 at 10:00 am

    ]]>(MedPage Today) -- People who took rivaroxaban (Xarelto) after lower-extremity revascularization for peripheral artery disease (PAD) enjoyed fewer subsequent major adverse limb and cardiovascular events, according to the VOYAGER PAD trial. The...

  • Vericiguat Cuts Admissions in HFrEF
    on 28/03/2020 at 10:00 am

    ]]>(MedPage Today) -- Novel oral agent vericiguat modestly reduced mortality and hospitalization among recently decompensated heart failure with reduced ejection fraction (HFrEF) patients in the pivotal VICTORIA trial. Once-daily doses of the soluble...